Evidence map›Paper›PMID 37020149›Full record

ArticleJournal of digital imaging2023

Skin Lesion Segmentation in Dermoscopic Images with Noisy Data.

Norsang Lama, Jason Hagerty, Anand Nambisan, Ronald Joe Stanley, William Van Stoecker

Abstract read
In one paragraph

Article in Journal of digital imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. LAMA: Lesion-Aware Mixup Augmentation for Skin Lesion Segmentation.Journal of imaging informatics in medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Norsang LamaMissouri University of Science &Technology, Rolla, MO, 65409, USA.
Jason HagertyS&A Technologies, Rolla, MO, 65401, USA.
Anand NambisanMissouri University of Science &Technology, Rolla, MO, 65409, USA.
Ronald Joe StanleyMissouri University of Science &Technology, Rolla, MO, 65409, USA. stanleyj@mst.edu.ORCID 0000-0003-0477-3388
William Van StoeckerS&A Technologies, Rolla, MO, 65401, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We propose a deep learning approach to segment the skin lesion in dermoscopic images. The proposed network architecture uses a pretrained EfficientNet model in the encoder and squeeze-and-excitation residual structures in the decoder. We applied this approach on the publicly available International Skin Imaging Collaboration (ISIC) 2017 Challenge skin lesion segmentation dataset. This benchmark dataset has been widely used in previous studies. We observed many inaccurate or noisy ground truth labels. To reduce noisy data, we manually sorted all ground truth labels into three categories - good, mildly noisy, and noisy labels. Furthermore, we investigated the effect of such noisy labels in training and test sets. Our test results show that the proposed method achieved Jaccard scores of 0.807 on the official ISIC 2017 test set and 0.832 on the curated ISIC 2017 test set, exhibiting better performance than previously reported methods. Furthermore, the experimental results showed that the noisy labels in the training set did not lower the segmentation performance. However, the noisy labels in the test set adversely affected the evaluation scores. We recommend that the noisy labels should be avoided in the test set in future studies for accurate evaluation of the segmentation algorithms.

Indexed as

MelanomaSkin DiseasesSkin NeoplasmsDermoscopyHumansImage Processing, Computer-AssistedNeural Networks, ComputerSkinDeep learningDermoscopyImage segmentationMelanomaNoisy data

Identifiers

PMID37020149
PMCPMC10407008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.